. Author manuscript; available in PMC: 2016 Jun 1.

Published in final edited form as: Clin Exp Allergy. 2015 Jun;45(6):1051–1059. doi: 10.1111/cea.12492

Table 1.

Baseline characteristics study population in the discovery phase

	BREATHE (n=820)	PAGES (n=391)	PACMAN (n=357)
Child characteristics
Age, range (yrs)	9.8 (2-22)	9.0 (2-16)	8.7 (4-13)^±
Male gender, %	61.2	55.8	61.1
Asthma exacerbations in preceding 12 months / 6 months
Asthma-related ED visit/hospital admission^*, %	19.0 (156/819)^§	15.5	6.2 (22/356)^§
Oral steroid use^*, %	31.6 (259/819)^§	43.2	6.2
BTS treatment step
2, %	65.9	48.8	71.7
3, %	18.3	42.2	23.0
4, %	15.9	9.0	5.3

BTS, British Thoracic Society,

PACMAN cohort: preceding 12 months, BREATHE/PAGES: preceding 6 months.

^§

data not available for all individuals; (number of individuals / number of individuals with data available). For BREATHE, the individual with missing hospital data is different from the individual with missing OCS data.

^±

Children within the PACMAN cohort were selected between the age of 4-12. However, the child might have been 13 at the moment of the study visit.